AI
Bayer and Exscientia will initially work on three early-stage projects using AI to speed up drug discovery.
Babyscripts CEO Anish Sebastian outlines major tech-driven trends to keep an eye on for the new year.
The AI system was able to reduce the percentage of false negative mammograms by 5.7% in the US and 1.2% in the UK.
Scale Venture Partners headed the round, which comes roughly a year and a half after OM1's $21 million Series B.
The new tool will also be localized to provide relevant medical information.
The investment will be used to build a clinical-stage portfolio for rare diseases, including treatments for Fragile X syndrome.
Q&A: Ieso Digital Health’s SVP of AI on digital therapeutics and the new Eight Billion Minds project
A chat with Valentin Tablan, SVP of AI at British mental health startup Ieso Digital Health.
The startup says it will use the investment to develop its AI solutions and market them internationally.
The round was led by European VC firm Atomico.
Despite data sharing concerns of the past, DeepMind's health team will be merging with Google Health.